Health

OliPass Discloses Painful but Hilarious Clinical Findings from a Phase 2a Trial in OA Patients with Nav1.7 Selective Inhibitor OLP-1002

SEOUL, South Korea, Nov. 13, 2023 /PRNewswire/ -- OliPass Corporation, an RNA therapeutics platform company, disclosed uncanny clinical findings from a multi-center Phase 2a trial with Nav1.7 selective OLP-1002 in osteoarthritis (OA) patients with moderate to severe pain inAustralia with Novotech...

2023-11-13 22:00 1311

Datasea Reports First Quarter Fiscal Year 2024 Financial Results and Operations Update

BEIJING, Nov. 13, 2023 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology company that develops and provides products utilizing intelligent acoustics including ultrasound, infrasound and directional sound, and provides 5G messaging, today announced its f...

2023-11-13 21:30 2163

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

* PYC has developed a new drug candidate for the >5 million people worldwide [1] with Polycystic Kidney Disease (PKD) * This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2] * PKD is a life-changing diseas...

2023-11-13 21:00 1361

AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests

GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectio...

2023-11-13 21:00 1266

So-Young's Subsidiary Wuhan Miracle Submits Application Documents for Initial Public Offering on China's Beijing Stock Exchange

BEIJING, Nov. 13, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that its subsidiary Miracle L...

2023-11-13 19:30 2024

BizLink once again proves its ability to innovate in healthcare robotics

At the MEDICA show in Duesseldorf, BizLink presents its new PULSAR platform, an ultrasafe and precise range of robotic arms for medical para-medical applications. CHARTRES, France, Nov. 13, 2023 /PRNewswire/ -- BizLink, a leading global interconnect solutions provider, announced the introduction...

2023-11-13 17:53 1909

Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates

CAMBRIDGE, Mass., Nov. 13, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, today announced that it has entered into a strategic collaboration with GeneQuantum Healthcare to advance the early discovery of next-gener...

2023-11-13 16:04 1285

111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow

SHANGHAI, Nov. 13, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial result...

2023-11-13 13:10 2314

One-Stop Dental 3D Printing Solutions Provider to Showcase at the GNYDM

NEW YORK, Nov. 12, 2023 /PRNewswire/ -- Chamlion, a digital dental expert, is set to showcase the design-print-polish solutions and diverse dental applications at the upcoming Greater New York Dental Meeting (GNYDM)inNew York.

2023-11-13 10:53 1481

PillWork Strengthens Global Ties Ahead of 2023 Launch with Strategic Partnerships

SEOUL, South Korea, Nov. 12, 2023 /PRNewswire/ -- PillWork, emerging as a pioneer in holistic wellness, is meticulously preparing for its anticipated launch at the end of 2023. As part of this build-up, PillWork has gained a place in the AWS Global Collaboration Program, ensuring top-tier app fu...

2023-11-13 08:00 1715

Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA

LEXINGTON, Mass., Nov. 11, 2023 /PRNewswire/ -- Fapon, a global leading life sciences organization, is thrilled to announce the grand opening of its US-based Research and Development (R&D) Center, strategically located in Lexington, Massachusetts. This Center represents Fapon's unwavering commitme...

2023-11-11 20:36 3030

SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York

One Retrospective Cohort, One Prospective Cohort, in Total of ~2,400 Cancer Patients and Non-cancer Individuals Demonstrate the Performance of SeekInCare Test to Detect Multiple Cancer Types and Predict Tissue of Origin of Cancers The Achievement of 65.5% Sensitivity at 97.9% Specificity in the ...

2023-11-10 21:00 1950

Lecheng, MSD vow to deepen medical cooperation

BEIJING, Nov. 10, 2023 /PRNewswire/ -- A news report from chinadaily.com.cn: MSD (Hainan) Innovative Medical Co Ltd is launched on Nov 6 during this year's CIIE. [Photo provided to chinadaily.com.cn] During the 6th China Int...

2023-11-10 18:03 2478

So-Young to Report Third Quarter 2023 Financial Results on November 20, 2023

BEIJING, Nov. 10, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its finan...

2023-11-10 18:00 1451

FEBICO actively seeking business partners in United States, introduces "High- Spermidine" chlorella health supplements to satisfy U.S. market

TAIPEI, Nov. 10, 2023 /PRNewswire/ -- FEBICO is Asia's largest organic microalgae producer and has been distributed to over 60 countries since 1990. Today, FEBICO becomes algae tech pioneer and visioner to bring the power of microalgae to the next level. C...

2023-11-10 17:08 1226

TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert

SAN FRANCISCO, Nov. 10, 2023 /PRNewswire/ -- On October 26, 2023, SyMap Medical invited ProfessorFelix Mahfoud, Vice-Chair of the Working Group Interventional Hypertension Treatment of the European Society of Hypertension (ESH) and a distinguished authority in the renal denervation (RDN) field, t...

2023-11-10 16:46 1425

GC Genome Enters License Agreement with MP Group

- Collaboration includes the transfer of GC Genome's essential wet lab know-how for SNP genotyping service. YONGIN, South Korea, Nov. 10, 2023 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it has entered into a collaboration and exclusive license agre...

2023-11-10 13:00 1752

MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results

SHENZHEN, China, Nov. 9, 2023 /PRNewswire/ -- On November 9, 2023, ImmVira announced the successful completion of Phase I clinical study conducted on late-stage patients with various tumor types for our intravenous oncolytic product, MVR-T3011 IV, inthe United States. This milestone was marked by...

2023-11-10 08:00 1804

Beyond2020 Improves Access to Clean Water for 10,000 Rural Malaysians

* Sustainable water fountains in 25 rural Malaysian communities provide clean, safe water, reducing waterborne illnesses ABU DHABI, UAE, Nov. 9, 2023 /PRNewswire/ -- Beyond2020, the UAE-driven humanitarian initiative, has installed water filters in 25 communities in theSabah and Sarawak regions...

2023-11-10 03:27 2337

PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data

* Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment.  * The starting dose (0.7mg) of PMC-403 showed potential in improving eyesight for neovascular age-related macular degeneration patients with suboptimal response to cur...

2023-11-09 21:00 1392
1 ... 51525354555657 ... 272